Equity Overview
Price & Market Data
Price: $453.8
Daily Change: +$7.33 / 1.62%
Daily Range: $442.0 - $454.7
Market Cap: $12,878,574,592
Daily Volume: 372,733
Performance Metrics
1 Week: 9.07%
1 Month: -26.88%
3 Months: -23.11%
6 Months: -2.57%
1 Year: 31.58%
YTD: -19.21%
Company Details
Employees: 6200
Sector: Commercial services
Industry: Miscellaneous commercial services
Country:
Details
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.